These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 15897742)
21. Strong PDGFRA positivity is seen in GISTs but not in other intra-abdominal mesenchymal tumors: Immunohistochemical and mutational analyses. Peterson MR; Piao Z; Weidner N; Yi ES Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):390-6. PubMed ID: 17122634 [TBL] [Abstract][Full Text] [Related]
22. Molecular and clinicopathological features of KIT/PDGFRA wild-type gastrointestinal stromal tumors. Nishida T; Naito Y; Takahashi T; Saito T; Hisamori S; Manaka D; Ogawa K; Hirota S; Ichikawa H Cancer Sci; 2024 Mar; 115(3):894-904. PubMed ID: 38178783 [TBL] [Abstract][Full Text] [Related]
23. Genetics of Gastrointestinal Stromal Tumors: A Heterogeneous Family of Tumors? Patil DT; Rubin BP Surg Pathol Clin; 2015 Sep; 8(3):515-24. PubMed ID: 26297068 [TBL] [Abstract][Full Text] [Related]
24. Classification of gastrointestinal stromal tumor syndromes. Gopie P; Mei L; Faber AC; Grossman SR; Smith SC; Boikos SA Endocr Relat Cancer; 2018 Feb; 25(2):R49-R58. PubMed ID: 29170162 [TBL] [Abstract][Full Text] [Related]
25. Jejunal gastrointestinal stromal tumor that developed in a patient with neurofibromatosis type 1: a case report. Nagano H; Ohyama S; Sato A; Igarashi J; Yamamoto T; Kadoya M; Kobayashi M Diagn Pathol; 2023 Oct; 18(1):110. PubMed ID: 37789344 [TBL] [Abstract][Full Text] [Related]
26. Long segmental hyperplasia of interstitial cells of Cajal with giant diverticulum formation. Xue L; Qiu T; Song Y; Shan L; Liu X; Guo L; Ying J; Zou S; Shi S; Polydorides AD; Zhao X; Lu N; Lin D Int J Clin Exp Pathol; 2013; 6(12):2989-96. PubMed ID: 24294389 [TBL] [Abstract][Full Text] [Related]
27. Detection of mutations in the BRAF gene in patients with KIT and PDGFRA wild-type gastrointestinal stromal tumors. Jasek K; Buzalkova V; Minarik G; Stanclova A; Szepe P; Plank L; Lasabova Z Virchows Arch; 2017 Jan; 470(1):29-36. PubMed ID: 27864688 [TBL] [Abstract][Full Text] [Related]
28. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST). Du CY; Shi YQ; Zhou Y; Fu H; Zhao G J Surg Oncol; 2008 Sep; 98(3):175-8. PubMed ID: 18618605 [TBL] [Abstract][Full Text] [Related]
29. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events. Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1. Mussi C; Schildhaus HU; Gronchi A; Wardelmann E; Hohenberger P Clin Cancer Res; 2008 Jul; 14(14):4550-5. PubMed ID: 18628470 [TBL] [Abstract][Full Text] [Related]
32. [Gastrointestinal stromal tumors in neurofibromatosis type 1]. Bajor J Orv Hetil; 2009 Jan; 150(4):149-53. PubMed ID: 19144598 [TBL] [Abstract][Full Text] [Related]
33. V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours. Agaimy A; Terracciano LM; Dirnhofer S; Tornillo L; Foerster A; Hartmann A; Bihl MP J Clin Pathol; 2009 Jul; 62(7):613-6. PubMed ID: 19561230 [TBL] [Abstract][Full Text] [Related]
34. Malignancies associated with GIST: a retrospective study with molecular analysis of KIT and PDGFRA. Mayr P; Märkl B; Agaimy A; Kriening B; Dintner S; Schenkirsch G; Schneider-Stock R Langenbecks Arch Surg; 2019 Aug; 404(5):605-613. PubMed ID: 30877378 [TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes. Liegl B; Hornick JL; Corless CL; Fletcher CD Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564 [TBL] [Abstract][Full Text] [Related]
36. Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size. Rossi S; Gasparotto D; Toffolatti L; Pastrello C; Gallina G; Marzotto A; Sartor C; Barbareschi M; Cantaloni C; Messerini L; Bearzi I; Arrigoni G; Mazzoleni G; Fletcher JA; Casali PG; Talamini R; Maestro R; Dei Tos AP Am J Surg Pathol; 2010 Oct; 34(10):1480-91. PubMed ID: 20861712 [TBL] [Abstract][Full Text] [Related]
37. [Status and clinical analysis of c-kit and PDGFRA mutations in the gastrointestinal stromal tumors]. Du CY; Shi YQ; Zhou Y; Fu H; Zhao GF Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):371-5. PubMed ID: 18636362 [TBL] [Abstract][Full Text] [Related]
38. Multiple gastrointestinal stromal tumors in type I neurofibromatosis: a pathologic and molecular study. Yantiss RK; Rosenberg AE; Sarran L; Besmer P; Antonescu CR Mod Pathol; 2005 Apr; 18(4):475-84. PubMed ID: 15540118 [TBL] [Abstract][Full Text] [Related]
39. Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours. Wang C; Jin MS; Zou YB; Gao JN; Li XB; Peng F; Wang HY; Wu ZD; Wang YP; Duan XM Scand J Gastroenterol; 2013 Sep; 48(9):1055-65. PubMed ID: 23862765 [TBL] [Abstract][Full Text] [Related]
40. High expression of the RNA-binding protein RBPMS2 in gastrointestinal stromal tumors. Hapkova I; Skarda J; Rouleau C; Thys A; Notarnicola C; Janikova M; Bernex F; Rypka M; Vanderwinden JM; Faure S; Vesely J; de Santa Barbara P Exp Mol Pathol; 2013 Apr; 94(2):314-21. PubMed ID: 23295309 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]